QWM
GILD icon

Quaker Wealth Management’s Gilead Sciences GILD Stock Holding History

Quaker Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-407
Closed -$45.6K – 1198
2025
Q1 		$45.6K Buy
+407
New +$42K 0.02% 162

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Quaker Wealth Management's GILD Position: Q2 2026 in Review

Quaker Wealth Management increased its Gilead Sciences (GILD) stake by 5% in Q2 2026, buying an estimated $6.46K and bringing the position to 1,038 shares worth $131K. The position accounts for 0.04% of the portfolio, ranked #96.

Quaker Wealth Management first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $138K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Quaker Wealth Management held 1,038 shares of Gilead Sciences worth $131K as of Q2 2026.
  • Quaker Wealth Management bought 49 Gilead Sciences shares in Q2 2026, an estimated $6.46K.
  • Gilead Sciences made up 0.04% of Quaker Wealth Management's portfolio in Q2 2026, its #96 holding.
  • Quaker Wealth Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's Gilead Sciences position peaked at $138K in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.